12:00 AM
 | 
Nov 05, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Kineret anakinra regulatory update

Swedish Orphan disclosed in its 3Q12 earnings that FDA accepted and granted Priority Review to a regulatory application to expand the label for Kineret anakinra to include...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >